Dr. Paul Magda, DO

Dr. Magda practices at Newyork-Presbyterian Medical Group/Queens in Yorktown Heights, New York.

Dr. Magda's NPI, 1750353561, was assigned on February 6, 2006. Dr. Magda graduated from LECOM at Seton Hill - Greensburg in 1997. Dr. Magda holds New York license 221739.

Dr. Magda's primary practice is Newyork-Presbyterian Medical Group/Queens, at 2649 Strang Blvd, Yorktown Heights, NY 10598 in Westchester County. The practice phone is (718) 670-1019.

Dr. Magda's primary practice is Newyork-Presbyterian Medical Group/Queens in Yorktown Heights, New York. Dr. Magda is also affiliated with NewYork-Presbyterian Queens. The medical group on file is NewYork-Presbyterian Medical Group Queens. Dmand AI also links Dr. Magda to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Magda practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Magda's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Magda is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Magda is licensed in New York.

Dmand AI lists alzheimer's disease, carpal tunnel syndrome, cerebrovascular disease, fibromyalgia and chronic pain, lower back pain, muscle disease, muscle pain, fibromyalgia, and limb pain and neuropathy among the conditions Dr. Magda treats.

CMS data shows 387 Medicare services from Dr. Magda across 12 procedure codes in 2024, for 234 Medicare patients. Medicare paid $39,701 for them.

CMS counts 234 Medicare patients who saw Dr. Magda in 2024. The largest group is 75 to 84, with 84 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 53% are also on Medicaid. Their average risk score is 2.45, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Magda's median patient age at 69, with 56% women.

In 2024, Dr. Magda wrote 827 Medicare Part D claims for 152 patients. 93% of them were for generic drugs. CMS names the drug for 643 of them, across 16 drugs with 11 or more claims each, at $67,856 in total drug cost. In 2023, CMS named 666 claims across 25 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Magda for performance year 2024, reported through an alternative payment model (APM). Dr. Magda accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Magda as offering telehealth.

Dmand AI links 8 papers to Dr. Magda in 2021. The most frequent topics are Immunoglobulins, Intravenous, Neural Conduction and Celiac Disease. Dr. Magda has published most often in Arch Neurol. Dr. Magda's most frequent co-authors are Norman Latov, MD, Thomas H. Brannagan, MD and Russell L. Chin, MD.

CMS Open Payments shows 18 general payments to Dr. Magda from 12 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $130.

Dmand AI lists 1 award for Dr. Magda, most recently CMS Stage 1 EHR in 2013.

Dr. Magda graduated from LECOM at Seton Hill - Greensburg in 1997. Dr. Magda is a member of AAN.

Dr. Magda is in network with 17 carriers, including Elevance, Aetna and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.